13.51
+1.35%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Inmode
Its shares trade under the ticker INMD. It has been listed since 8 August 2019. In the fiscal year to 31 December 2025, it reported revenue of $370.5m and net income of $93.8m. At that date it held total assets of $766.4m and shareholders' equity of $683.2m.
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. The company designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. The company owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Aug 2019
- Employees
- 660
- Head office
- TAVOR BUILDING, SHA?AR YOKNEAM, YOKNEAM, L3, 2069200
- Incorporated in
- L3
- Classification
- Electromedical & Electrotherapeutic Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Dr. Michael AnghelIndependent Chairman of the Board$221,000
- Mr. Moshe MizrahyChief Executive Officer, since 2008$216,000
- Mr. Yair MalcaChief Financial Officer$1.5m
- Mr. Michael DennisonPresident, North America$2.0m
- Dr. Michael KreindelChief Technology Officer, Director, since 2008$267,000
- Mr. Nadav KennethIndependent Director
- Dr. Hadar RonIndependent Director
- Ms. Miri Segal-SchariaCEO - MS IR LLC
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Innovation-driven: Inmode Ltd is known for its continuous innovation in the medical aesthetics industry, offering advanced technologies and treatment options.
- Strong product portfolio: The company has a diverse range of high-quality products and solutions, including minimally invasive and non-invasive treatments, which cater to various customer needs.
- Established brand: Inmode Ltd has built a solid reputation and brand presence in the market, gaining trust and recognition from both healthcare professionals and patients.
Weaknesses
- Dependence on key markets: Inmode Ltd heavily relies on specific geographic regions, which may expose the company to market-specific risks and fluctuations.
- Limited global reach: While the company has expanded its presence internationally, it still has room for further expansion to tap into untapped markets and increase market share.
- Intense competition: Inmode Ltd faces fierce competition from other established players and emerging companies in the medical aesthetics sector. Maintaining and expanding market share can be challenging.
Opportunities
- Growing demand for non-invasive treatments: The increasing preference for non-surgical aesthetic procedures presents an opportunity for Inmode Ltd to further expand its product offerings and capture a larger market share.
- Rising consumer awareness: As consumer awareness about the benefits of aesthetic treatments increases, there is a potential for Inmode Ltd to educate and attract more customers, driving demand for its products.
- Technological advancements: By staying at the forefront of technological advancements, Inmode Ltd can continue to develop and introduce innovative solutions, strengthening its competitive position in the market.
Threats
- Regulatory challenges: Government regulations and guidelines related to medical devices and aesthetic treatments can pose challenges and impact the market potential of Inmode Ltd.
- Economic downturns: In times of economic uncertainty or recessions, consumers may reduce their discretionary spending on aesthetic treatments, leading to a potential decline in demand for Inmode Ltd's products.
- Counterfeit products and unauthorized distributors: The presence of counterfeit products and unauthorized distributors can harm Inmode Ltd's brand reputation and result in revenue losses.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.